Valeant Pharmaceuticals Intl Inc (VRX) is Expanding its Eye Care Business
The pharmaceutical industry is getting hotter with increasing M&A activities.
Posts Tagged ‘NYSE:AGN’
Allergan, Inc. (AGN), Novo Nordisk A/S (ADR) (NVO): Should These Drug Companies Continue to Pay a Dividend?
Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend.
Do Hedge Funds and Insiders Love Allergan, Inc. (AGN)?
Allergan, Inc. (NYSE:AGN) was in 31 hedge funds' portfolio at the end of the first quarter of 2013. AGN has seen a decrease in hedge fund interest in recent months.
Allergan, Inc. (AGN), Dr. Reddy’s Laboratories Limited (ADR) (RDY): Should These Drug Companies Pay a Dividend?
Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and Insiders Are Bearish, What Should You Do?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was in 47 hedge funds' portfolio at the end of March. TEVA has experienced a decrease in hedge fund sentiment of late.
Allergan, Inc. (AGN): Is It Worth Looking At?
Allergan, Inc. (NYSE:AGN) has been consistently increasing on the market since the market bottom, from nearly $32 per share in November 2008 to more than $116 per share in ...
Merck & Co., Inc. (MRK), AVEO Pharmaceuticals, Inc. (AVEO): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Allergan, Inc. (AGN), Regeneron Pharmaceuticals Inc (REGN), And What You Should Know
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Allergan, Inc. (AGN): This Stock Waits to Exhale
Allergan, Inc. (NYSE:AGN) announced today that the Food and Drug Administration issued a complete response letter for Levadex, an inhalable drug that treats migraines.
Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK), and Three ‘Cannot Miss’ FDA Actions This Week
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration...
Alcoa Inc (AA), F5 Networks, Inc. (FFIV) & More: Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) – Forest Laboratories, Inc. (NYSE:FRX), Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY)
To most stock holders, hedge funds are assumed to be slow, outdated financial tools of the past.
Allergan, Inc. (NYSE:AGN): Hedge Funds and Insiders Are Bearish, What Should You Do?
In the eyes of most shareholders, hedge funds are seen as underperforming, old financial vehicles of the past.
3 Health Stocks that Look Pretty: Allergan, Inc. (AGN), Align Technology, Inc. (ALGN), Cynosure, Inc. (CYNO)
Sales growth in the beauty, personal care, and aesthetic treatment market in the United States doubled the average consumer spending rate growth in 2011 and in 2012.
Spectrum Pharmaceuticals, Inc. (SPPI) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Allergan, Inc. (AGN): No Sign of a Slowdown at This Recession Resistant Company
I must confess I am finding the current market to be one of the most frustrating periods of my investing life.
